Glycerin Pharmaceutical USP/EP/JP (Pharmacopeial-Grade Trihydric Alcohol Humectant Solvent Cryoprotectant) Storage

Glycerin Pharmaceutical USP/EP/JP (Pharmacopeial-Grade Trihydric Alcohol Humectant + Solvent + Cryoprotectant) Storage — Compendial-Grade Glycerin Tank Selection at Pharmaceutical Manufacturing Facilities, Compounding Pharmacies, Vaccine Plants, and Biologics Cryopreservation Service

Glycerin Pharmaceutical USP (also called glycerol USP, glycerine USP, 1,2,3-propanetriol; CAS 56-81-5; molecular formula C₃H₈O₃; molecular weight 92.09 g/mol) is a clear, colorless, odorless, sweet-tasting, hygroscopic, viscous trihydric alcohol meeting the United States Pharmacopeia 43 - National Formulary 38 Glycerin monograph, the European Pharmacopoeia 11.0 Glycerol monograph (Glycerolum 85% and anhydrous), the Japanese Pharmacopoeia 18 Glycerin monograph, and harmonized ICH Q3D elemental impurities and ICH Q3C residual solvents requirements. Compendial pharma-grade glycerin assays at 99.0-101.0% C₃H₈O₃ (anhydrous basis), water under 5.0% by Karl Fischer (USP 921), residue on ignition under 0.01%, heavy metals under 5 ppm, chloride under 0.001%, sulfate under 0.002%, fatty acids and esters under 1.0 mL of 0.5 N NaOH per 50 g, and the critical diethylene glycol (DEG) and ethylene glycol (EG) limit of under 0.10% each per the USP <467> Limit of Diethylene Glycol and Ethylene Glycol identification + quantification test mandated after the 1996 Haitian acetaminophen syrup mass-poisoning event and reaffirmed by 21 CFR 211.84(d)(2) post-2007 Panama cough-syrup contamination + 2022 Gambia + Indonesia pediatric DEG fatalities.

Pharmaceutical USP glycerin is used as humectant + solvent + viscosity-modifier + sweetener in oral pediatric syrups, elixirs, oral solutions, suppositories, suppository bases (PEG + glycerin blends), ophthalmic and otic drop formulations, topical creams + lotions + ointments, dermal patches, mouthwashes + toothpastes (oral-care OTC), vaccine adjuvant + freeze-dry stabilizer matrices, and as cryoprotectant in biologics + cell-and-gene therapy + autologous tissue + sperm + oocyte + embryo + cell-culture cryopreservation programs at 5-15% v/v in CPA cocktails (commonly with DMSO, propylene glycol, sucrose, trehalose, hydroxyethyl starch). Physical properties: density 1.261 g/cm³ at 20°C; specific gravity 1.261; viscosity 1410 cP at 20°C dropping to 152 cP at 50°C and 22 cP at 100°C; flash point 160°C closed cup; autoignition 370°C; melting point 17.8°C anhydrous (commercially handled at 25-40°C tank-heating to maintain pumpable viscosity); boiling point 290°C (decomposes above 280°C to acrolein); fully water-miscible at all proportions; hygroscopic equilibrium 50-60% RH at room temperature.

The eight sections below cite USP-NF 43, Ph. Eur. 11.0, JP 18, FDA 21 CFR Parts 210 + 211 (cGMP for finished pharmaceuticals), 21 CFR Part 600-680 (biologics cGMP), 21 CFR 211.84 (raw-material identification + DEG/EG testing), USP <467> Residual Solvents, USP <1116> Microbial Bioburden, USP <1231> Water for Pharmaceutical Purposes, ASME Bioprocessing Equipment (BPE-2022) for hygienic stainless steel construction, FDA Guidance for Industry: Testing of Glycerin for Diethylene Glycol (May 2007 + 2022 update), ICH Q7 + Q9 + Q10, and operating practice at Pfizer, Merck, GlaxoSmithKline, Sanofi, AbbVie, Gilead, Regeneron, Moderna, Lonza, Catalent, Patheon (Thermo Fisher), and similar large + mid-size pharmaceutical and CDMO + CMO manufacturing operations for compendial glycerin storage and dispensing in oral, parenteral, ophthalmic, topical, biologics, and cryopreservation service envelopes.

1. Material Compatibility Matrix

Pharmaceutical USP glycerin is a chemically gentle aqueous-miscible polyol with no oxidizer character, no acid character, neutral pH 7 (anhydrous) to 6 (commercial 99.7% glycerin with trace water), and no halogen or sulfur species. The dominant material-selection driver in pharma service is not chemical attack but compendial cleanliness, leachables + extractables (L&E) profile, and validated hygienic design. The matrix below covers both bulk-receipt + bulk-storage applications (where HDPE rotomolded tanks are appropriate at compounding pharmacies + non-cGMP industrial-pharma-feedstock storage) and product-contact / formulation service (where 316L electropolished stainless to ASME BPE is mandatory).

The dominant industrial pattern at pharmaceutical manufacturing is two-stage: HDPE or XLPE rotomolded tanks at the bulk-receipt warehouse + compounding pharmacy ingredient warehouse for raw-material drum + tote + bulk-tanker receipt and short-term staging, then transfer through 316L electropolished sanitary piping to ASME BPE 316L formulation vessels for product-contact service.

2. Real-World Industrial Use Cases

Oral Liquid Pharmaceutical Manufacturing. USP glycerin is the dominant humectant + cosolvent + sweetener in pediatric and geriatric oral liquid dosage forms: cough suppressant syrups (dextromethorphan, guaifenesin), antihistamine elixirs (diphenhydramine, promethazine), antibiotic suspensions (amoxicillin, azithromycin oral), iron supplements, vitamin syrups, and oral-rinse preparations. Typical inclusion 5-25% w/v; functions as anti-crystallization agent + sweetener (60% relative sweetness vs. sucrose) + viscosity modifier + microbial-load preservative (water activity reduction). Major formulation houses: Pfizer Children's Tylenol, Johnson & Johnson Children's Motrin, GSK Robitussin, Reckitt Mucinex.

Suppository and Enema Manufacturing. Glycerin USP is the active ingredient in glycerin suppositories (Fleet glycerin suppositories, Pedia-Lax) for pediatric + adult constipation; also a base component in PEG + glycerin suppository systems for hormonal + analgesic + antiemetic delivery. Pharmacopeial 99.5%+ glycerin is required for direct active-pharmaceutical-ingredient (API) use. Manufacturing at Fleet Pharmaceuticals (C. B. Fleet), Perrigo, Sun Pharma, and similar OTC contract manufacturers.

Ophthalmic and Otic Drop Manufacturing. USP glycerin is included in ophthalmic artificial-tear formulations (Refresh, Systane, Opcon-A) at 0.2-1.0% concentration as demulcent + viscosity modifier + osmolality adjuster. Otic preparations (Debrox carbamide peroxide ear drops + Auro-Dri) include glycerin at 5-25% as solvent + drying agent. These applications require sterile + low-bioburden + low-endotoxin glycerin meeting USP <71> sterility, USP <85> bacterial endotoxins, and USP <788> particulate-matter testing.

Topical Cream + Lotion + Ointment Manufacturing. Glycerin USP is the dominant humectant in dermatologic OTC + Rx topical preparations: hydrocortisone creams, Lubriderm + Cetaphil + Eucerin moisturizers, Aquaphor ointment base, and a wide range of OTC anti-itch + first-aid + diaper-rash preparations. Inclusion 3-15% w/w; co-formulated with petrolatum, mineral oil USP, lanolin USP, ceresin, and emulsifier systems (cetearyl alcohol, glyceryl stearate, polysorbates). Dermatology + skincare manufacturing at Beiersdorf, L'Oreal Active Cosmetics, Galderma, Almirall, Bausch Health, Pierre Fabre.

Vaccine Adjuvant + Lyophilization Stabilizer. USP glycerin functions as freeze-dry stabilizer + cake-former in vaccine + biologic lyophilization formulations, particularly in legacy live-attenuated viral vaccine formats and in some adjuvanted vaccine systems. Inclusion 5-15% in pre-lyophilization formulation with sucrose, trehalose, mannitol, polysorbate-80, and buffer salts. Vaccine manufacturing at Merck, Pfizer, Sanofi Pasteur, GSK Vaccines, Serum Institute of India.

Biologics + Cell-and-Gene Therapy Cryopreservation. Glycerin USP is included in cryoprotectant agent (CPA) cocktails for biologic + cell-and-gene therapy cryopreservation: peripheral blood mononuclear cells (PBMC), CAR-T cells (Yescarta, Kymriah, Tecartus, Breyanzi, Carvykti, Abecma), induced pluripotent stem cells (iPSC), mesenchymal stem cells (MSC), and autologous + allogeneic cell-therapy products. Typical formulation 5-10% v/v glycerin combined with 5-10% v/v DMSO, hydroxyethyl starch (HES), human serum albumin (HSA), and sucrose or trehalose. Cryopreservation manufacturing at Bristol Myers Squibb, Gilead Kite, Novartis, Janssen, Vertex, BioNTech, Lonza, Catalent, Patheon (Thermo Fisher), Charles River Laboratories.

Compounding Pharmacy Ingredient Stocking. Compounding pharmacies (PCCA, Medisca, Letco Medical, Spectrum Chemical) stock USP glycerin in 1-pint bottles to 55-gallon drums to 275-gallon IBC totes for use in patient-specific compounded preparations under USP <795> non-sterile compounding + USP <797> sterile compounding + USP <800> hazardous-drug compounding standards. Bulk drum + tote receipt at the compounding pharmacy ingredient warehouse uses HDPE rotomolded short-term storage at the receiving dock + warehouse staging area before drumming to small-volume working stocks.

3. Regulatory Hazard Communication

OSHA HazCom GHS Classification. USP pharmaceutical glycerin is not classified as a GHS hazardous substance. No physical-hazard classification (flash point 160°C is well above the Class IIIB combustible-liquid threshold but below DOT regulatory thresholds; non-flammable in normal handling); no health-hazard classification at oral, dermal, or inhalation routes (extensive feeding-study + dermal + inhalation safety testing places glycerin at GRAS / Generally Recognized As Safe per FDA 21 CFR 182.1320, 184.1322, 582.1320); no environmental-hazard classification (rapidly biodegradable; fish LC₅₀ over 5000 mg/L). H-statements: none required. P-statements: P210 Keep away from open flames + hot surfaces (only at heated bulk-storage above flash point); P403+P233 Store in well-ventilated container kept tightly closed; otherwise no precautionary statements required.

FDA cGMP Compliance Framework. Pharmaceutical USP glycerin used in finished drug products is regulated under FDA cGMP at 21 CFR Part 210 + 211 (finished pharmaceuticals) for raw-material identification, sampling, testing, retention, and disposition. The raw-material identity test at 21 CFR 211.84(d)(2) requires at least one specific identity test on each container of glycerin received; FDA Guidance for Industry: Testing of Glycerin for Diethylene Glycol (May 2007) further mandates the USP <467> DEG + EG limit test on every container of glycerin used in finished drug products to prevent recurrence of the 1995-2006 mass-poisoning events from DEG-contaminated glycerin (Haiti 1996, Panama 2006, Nigeria 2008, India 1998, Bangladesh 1990s). The 2022 Gambia + Indonesia pediatric DEG fatalities (over 300 deaths) reaffirmed the criticality of DEG/EG testing on every glycerin lot.

USP-NF 43 + Ph. Eur. 11.0 + JP 18 Compendial Specifications. Pharmacopeial harmonized glycerin specifications: assay 99.0-101.0% (USP) or 86-90% (Ph. Eur. Glycerolum 85%) or 95-101% (Ph. Eur. anhydrous); identification by IR spectrum, refractive index 1.470-1.475 at 20°C, specific gravity 1.249 minimum; water content under 5.0% by Karl Fischer; residue on ignition under 0.01%; heavy metals under 5 ppm; chloride under 0.001%; sulfate under 0.002%; fatty acids and esters under 1.0 mL of 0.5 N NaOH per 50 g; chlorinated compounds under 30 ppm; aldehydes (color reaction with ammoniacal silver nitrate) negative; sugars (Molisch test) negative; DEG + EG each under 0.10% per USP <467>; ICH Q3D elemental impurities (As, Cd, Hg, Pb under PDE limits for parenteral/oral routes); ICH Q3C residual solvents (Class 1 + Class 2 limits).

DOT and Shipping. USP glycerin is not regulated under 49 CFR DOT Hazardous Materials Regulations at any concentration; no UN number, no hazard class, no packing group required. Shipped as standard non-hazardous liquid in HDPE drums (5-gallon, 15-gallon, 30-gallon, 55-gallon), HDPE 275-gallon and 330-gallon IBC totes, FDA-grade HDPE poly-blend sanitary tanks at compounding pharmacies, and stainless or HDPE tank trucks at bulk pharmaceutical-feedstock movements.

EPA Air Regulations. Glycerin storage tanks are not subject to 40 CFR Part 60 NSPS Subpart Kb (vapor pressure threshold 0.75 psi; glycerin vapor pressure under 0.001 psi at room temperature far below threshold); no Subpart K or KKK applicability. Pharmaceutical manufacturing facilities are subject to 40 CFR Part 63 Subpart GGG Pharmaceuticals Production NESHAP for air emissions of organic HAPs at the manufacturing process; glycerin is not listed as a HAP and is not a regulated emission source.

FDA GRAS Status for Food and Pharmaceutical Use. Glycerin holds GRAS status per 21 CFR 182.1320 (general-purpose food additive), 184.1322 (direct human food additive affirmed GRAS), and 582.1320 (animal feed). Used as humectant + sweetener + solvent + carrier + plasticizer in food + pharmaceutical + dietary-supplement products without inclusion-level limit per 21 CFR 184.1322(b) "used in food generally subject only to good manufacturing practice."

4. Storage System Specification

Bulk-Receipt and Raw-Material-Warehouse Storage. Pharmaceutical USP glycerin arrives at the manufacturing facility raw-material warehouse via 5-gallon pails, 55-gallon HDPE drums, 275-330-gallon HDPE IBC totes, or stainless / HDPE-lined tank trucks (4500-6500 gallon delivery). Bulk-tanker deliveries at large pharmaceutical operations transfer to dedicated bulk-receipt storage tanks: HDPE rotomolded vertical 1500-15000-gallon vessels, FDA-grade HDPE-blend with sanitary 4-inch BSP tank-top fill, 4-inch ANSI bottom flanged outlet, atmospheric vent with inline 0.2-micron sterilizing-grade hydrophobic vent filter (Pall Sealkleen, Sartorius Sartopore, Donaldson PTFE), tank-mounted level transmitter (radar or guided-wave), and tank-jacket warming or trace-heat to maintain 30-40°C handling temperature (glycerin viscosity drops from 1410 cP at 20°C to 152 cP at 50°C, dramatically improving pumping + transfer at modest heating).

Tank Sizing. Typical bulk-receipt tank sizes: 1500-3000 gallons at compounding pharmacies + small-batch sterile-fill operations; 5000-10000 gallons at mid-size pharmaceutical manufacturing; 15000-30000 gallons (multiple HDPE tanks in parallel manifold) at large-scale oral-syrup + topical-cream + biologics formulation. Tank sizing accounts for typical 30-day forward-stock requirement plus 2-week safety stock plus delivery cadence (weekly to monthly bulk-tanker delivery).

Compounding Pharmacy Working-Stock Storage. Compounding pharmacies + 503A facilities + 503B outsourcing-facility operations stock glycerin USP in 5-30 gallon HDPE drums at the ingredient warehouse + sterile compounding anteroom + non-sterile compounding cleanroom. Drum + tote receiving uses HDPE pump dispensing into smaller working stocks. Working stocks at the BSC (biological safety cabinet) or compounding bench are dispensed from FDA-grade HDPE bottles or USP-spec amber-glass bottles.

Product-Contact Formulation Tanks. Active formulation + compounding for finished oral / topical / ophthalmic / parenteral / biologic preparations occurs in 316L electropolished sanitary stainless tanks per ASME BPE-2022 with internal surface finish Ra under 0.5 microns, all-welded 316L sanitary tri-clamp transfer piping, BPE diaphragm or ball valves, jacketed temperature control (chilled-water or steam), top-mounted impeller agitation (sanitary mechanical seal), CIP/SIP capability via spray-ball + steam-trap installation, and validated cleaning + steam-in-place cycles. These vessels are outside the HDPE network and are not OneSource scope; we coordinate referral to ASME BPE fabricators for product-contact stainless service.

Secondary Containment. Bulk-receipt HDPE storage vessels at pharmaceutical operations are placed inside HDPE secondary-containment pans sized to 110% of the largest single tank capacity per EPA SPCC 40 CFR Part 112 (despite glycerin not being an oil + not being a hazardous substance under CERCLA 103, facility-wide containment best-practice extends SPCC discipline to all bulk liquid storage). Containment pan + tank assembly placed on flat-pour concrete pad inside the manufacturing facility's bulk-receipt area or warehouse outside the cleanroom envelope.

Heated Tank Service. Tank-jacket warming (steam half-pipe coil or electric trace + insulation) at 30-40°C dramatically reduces glycerin viscosity and is the dominant industrial pattern at mid- and large-scale pharma + cosmetic manufacturing. HDPE jacketed tanks are not common at pharma scale; the typical pattern is HDPE bulk-receipt at ambient + transfer-pump heated + pre-conditioned at the formulation tank, or jacketed 316L sanitary tank from receipt onward at the largest operations.

5. Field Handling Reality

Operator PPE. Pharmaceutical operators handling USP glycerin require standard pharmaceutical manufacturing PPE: cleanroom-grade gowning at sterile + cleanroom operations (Tyvek IsoClean or equivalent disposable cleanroom suit, hood, mask, latex or nitrile inner + outer gloves, sterile boot covers, goggles + face shield), safety glasses + lab coat + closed-toe shoes at non-cleanroom ingredient warehouse + bulk-receipt operations, nitrile gloves at all liquid-handling operations to prevent cross-contamination of finished product (glycerin itself is non-irritating; PPE protects product integrity, not operator). Spill-response gear (absorbent pads, neutralizer-not-required, mop kit) at the bulk-receipt area. No respirator required at any handling temperature; no splash-shield required beyond standard safety glasses.

Microbial Bioburden Control. Glycerin's water activity (a_w) of 0.30 at the 99.5% commercial concentration places it well below the 0.86 threshold for bacterial growth and below the 0.65 threshold for mold + osmophilic yeast growth, making concentrated USP glycerin self-preserving against microbial contamination. Diluted aqueous glycerin solutions (under 60% w/w) lose this self-preservation and require either microbial preservation (parabens, phenoxyethanol, sorbate, benzoate; concentrations and selection driven by USP <51> antimicrobial effectiveness testing) or sterile-filtered + closed-system handling. Bulk-receipt + warehouse storage of concentrated USP glycerin (under 5% water) does not require preservative addition; dilution into formulation triggers the preservation framework.

Spill Response. Glycerin spill response at pharmaceutical manufacturing facilities is a low-hazard standard cleanup: (1) deploy absorbent pads or floor-sweep granular absorbent (vermiculite, diatomaceous earth, oil-only sorbent inappropriate, water-based sorbent appropriate), (2) collect into double-bagged poly waste for pharmaceutical-waste profiling and disposal under facility-specific waste streams (typically non-RCRA, non-hazardous, sometimes profiled for incineration if cross-contaminated with API residues), (3) wash spill area with hot water + mild detergent (glycerin's high water-solubility makes water + detergent the appropriate decontamination route; concrete sealants and floor coatings require post-spill inspection for slip hazard from residual glycerin film), (4) document spill volume + decontamination + containment integrity for the facility deviation + investigation system per 21 CFR 211.192.

Slip Hazard. Glycerin's low coefficient of friction on hard floors creates a meaningful slip hazard at any bulk-receipt drum-handling + tote-handling + tank-fill operation. Slip-resistant floor mats + secondary containment + floor cleaning protocols are essential at the bulk-receipt staging area; pharmacy + manufacturing facility safety programs include glycerin spill in the standard slip-trip-fall hazard inventory under OSHA 29 CFR 1910.22 General Walking-Working Surfaces and OSHA 29 CFR 1910 Subpart D housekeeping requirements.

Decontamination of Cross-Contamination Spills. Pharmaceutical manufacturing under 21 CFR 211.42 + 21 CFR 211.46 + 21 CFR 211.67 cleaning + cross-contamination prevention requires documented cleaning of any spill area + adjacent equipment + drains + transfer-piping returning to compendial-clean status. Glycerin spill cleanup at a dedicated raw-material warehouse area is straightforward; spill at a multi-product compounding bench triggers cross-contamination investigation, equipment-cleaning verification, and quality-deviation closure before resumption of compounding.

Talk to OneSource Plastics

Listed price covers tank + standard fitting package; LTL freight is quoted separately to your delivery ZIP. Call 866-418-1777, use our freight estimator, or try our chemical tank recommender to narrow material selection.